- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 451/14 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamineCyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantaneCyclic acetals thereof
Patent holdings for IPC class C07D 451/14
Total number of patents in this class: 167
10-year publication summary
11
|
8
|
11
|
21
|
19
|
10
|
10
|
10
|
5
|
5
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Skyhawk Therapeutics, Inc. | 110 |
18 |
Theravance Biopharma R&D IP, LLC | 458 |
14 |
Purdue Pharma L.P. | 499 |
12 |
Nxera Pharma UK Limited | 169 |
8 |
Nippon Soda Co., Ltd. | 894 |
6 |
Merck Patent GmbH | 5830 |
5 |
Nissan Chemical Industries, Ltd. | 1717 |
5 |
Washington University | 1609 |
5 |
Novartis AG | 10847 |
4 |
The Regents of the University of California | 19898 |
4 |
The Scripps Research Institute | 1346 |
4 |
Agency for Science, Technology and Research | 3616 |
3 |
Astraea Therapeutics, LLC | 12 |
3 |
Ludwig Institute for Cancer Research Ltd | 190 |
3 |
Shionogi & Co., Ltd. | 858 |
3 |
Tohoku Techno Arch Co., Ltd. | 127 |
3 |
Tohoku University | 2780 |
3 |
F. Hoffmann-La Roche AG | 7930 |
2 |
Abbott Laboratories | 2402 |
2 |
Bayer Pharma AG | 1053 |
2 |
Other owners | 58 |